Zevra Therapeutics reposted this
UCD research explained: An important new study shows that female OTC carriers face both symptoms and health risks at higher levels than previously thought. They should be monitored to reduce risks and possibly treated to address symptoms that may have gone unrecognized. Read more here: https://shorturl.at/QsLDn #UCDC #ucdresearchexplained #UCDs #OTC #ureacycledisorder #ureacycledisorders #ucdresearch
Today we announced that our company will acquire Acer Therapeutics Inc., effectively expanding our rare disease portfolio and accelerating our growth into a commercial company. The acquisition brings us unique rare disease commercial capabilities that will support our existing pipeline as it advances. We are encouraged by the strength of Acer’s portfolio of rare programs and are excited to foster our shared goal of bringing life changing therapeutics to patients with significant unmet needs. Join our conference call today, 8/31 at 8:30 a.m. ET to learn the details of the acquisition: https://bit.ly/47MqzQk Read the full announcement here: https://bit.ly/44FZTOE #WeAreZevra
Zevra Therapeutics is pleased to present 4 posters highlighting new clinical data on #arimoclomol, an investigational therapy, for #NiemannPick disease type C and 1 poster on pharmacokinetic modeling of nitrogen scavengers and #OLPRUVA for #UreaCycleDisorders at the SSIEM 2024 Annual Symposium. Find more details on the conference here: https://bit.ly/3XsAKGw #SSIEM2024 #NPC #UCDs
"Our ultimate goal is to provide hope and improved outcomes for patients and their families.” Cindy Parseghian https://lnkd.in/duvtWWH3
Zevra Therapeutics is a proud sponsor of the International Network for Fatty Acid Oxidation Research and Management (INFORM) 2024 Symposium September 1-2, in Porto, Portugal. Find more details on the event here: https://bit.ly/3TbGH8f #NiemannPick #NPC
Have you registered for Cure the Cycle yet? There is still time to register as a VIRTUAL rider! Sign up to ride at https://lnkd.in/eWDWzWrc or text 'Curethecycle' to (833) 755-6550! #curethecycle #ureacycle #ureacycledisorder #ureacycledisorders #nucdf #raredisease #rarelife #rarediseases
Zevra Therapeutics will participate in upcoming investor conferences, including the H.C. Wainwright & Co., LLC 26th Annual Global Investment Conference and the Cantor Fitzgerald 2024 Global Healthcare Conference. For more information, check the release: https://bit.ly/4dEYEEp #CantorHCC #InvestorRelations
#ICYMI: Our Chief Medical Officer, Adrian Quartel, discussed how our phase 2 results of #KP1077 for treating #IdiopathicHypersomnia showed clinically meaningful results and set up the foundation for designing a phase 3 trial with Chelsie Derman of HCPLive. Check it out: https://bit.ly/3Ytfa5C
What do you wish everyone knew about aortic dissection's risk and impact? Tell us in comments, and we'll use your words to raise awareness this September. If you'd like to share a personal story in longer form, email brandcomms@marfan.org with your thoughts. Thank you for helping to save lives. #loeysdietz #marfan #VEDS #aorta #aorticdissection #awareness
Dr. Lindsay Burrage, M.D., Ph.D., of Baylor College of Medicine, shared new insights on liver disease at our 2024 conference. See the presentation here: https://lnkd.in/eq232v27 #liverdisease #liver #ureacycle #urea #ureacycledisorder #metabolicdisease #geneticdisorders #metabolicdisorders #rarediseaseresearch
